Results 171 to 180 of about 6,026 (204)

Cross-resistance to cefiderocol and ceftazidime–avibactam in KPC β-lactamase mutants and the inoculum effect

Clinical Microbiology and Infection, 2021
Claire Amaris Hobson, Olivier Tenaillon, André Birgy   +2 more
exaly  

Cefiderocol

Reactions Weekly, 2020
openaire   +1 more source

Cefiderocol/colistin

Reactions Weekly, 2023
openaire   +1 more source

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

Lancet Infectious Diseases, The, 2021
Richard G Wunderink, Mari Ariyasu, Philippe Clevenbergh   +2 more
exaly  

Cefiderocol/cotrimoxazole

Reactions Weekly, 2023
openaire   +1 more source

Cefiderocol/colistin

Reactions Weekly, 2020
openaire   +2 more sources

New Delhi Metallo-Beta-Lactamase Facilitates the Emergence of Cefiderocol Resistance in Enterobacter cloacae

Antimicrobial Agents and Chemotherapy, 2022
Dennis Nurjadi, Ali Kaan Kocer, Sabrina Klein   +2 more
exaly  

Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase–Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies

Clinical Infectious Diseases, 2022
Mical Paul, Ryan K Shields
exaly  

Cefiderocol in context

The Lancet Infectious Diseases, 2018
openaire   +3 more sources

Cefiderocol/colistin

Reactions Weekly, 2021
openaire   +1 more source